A 35-year-old mother, Jaclyn Hayes Lin, received a devastating diagnosis of stage 4 pancreatic cancer while being 32 weeks pregnant, a situation that would be every expectant mother’s worst nightmare. Harnessing an extraordinary level of resilience and determination, Jaclyn has not only managed to fight against the odds but has also become an advocate for pancreatic cancer research, particularly during a time when funding for such critical studies is being cut back significantly.
:max_bytes(150000):strip_icc():format(jpeg)/Jaclyn-Hayes-Lin-402-111025-6ecc6bab61284bd3bdded82a1e1d67a4.jpg)
Jaclyn’s journey began with unusual symptoms during her second pregnancy, such as a lack of cravings and weight gain, which raised concerns that something was amiss. Visits to the ER due to severe back pain eventually led to the chilling diagnosis of stage 4 pancreatic cancer. Despite the devastating news, Jaclyn’s focus swiftly shifted to finding a way to stay alive for her two daughters, leading her to volunteer with Pancreatic Cancer Action Network and participate in clinical trials to explore life-saving treatment options.
The turmoil continued as Jaclyn faced excruciating pain, fever, and flu-like symptoms, leading to multiple hospital visits before the dreadful revelation of a large mass on her pancreas and metastasis to her liver. The situation escalated rapidly, culminating in the premature birth of her second daughter to prioritize her own treatment. Despite the whirlwind of emotions and physical challenges, Jaclyn’s steely resolve and the unwavering support of her husband saw her through the turbulent times.
Navigating through rounds of traditional chemotherapy, Jaclyn eventually found a lifeline through a new medication, BIZENGRI, which marked a significant shift in her treatment journey. Unlike the draining effects of chemotherapy, this new drug allowed her to enjoy precious moments with her daughters, further underscoring the importance of exploring innovative treatment options beyond conventional approaches.
Despite the grim statistics associated with stage 4 metastatic pancreatic cancer, Jaclyn’s story shines as a beacon of hope and resilience. With the support of her family and cutting-edge treatments, she has seen a substantial reduction in her tumours, prompting cautious optimism from her medical team. Living life in three-month increments, marked by routine CT scans and treatment assessments, Jaclyn embodies strength and positivity in the face of uncertainty.
While the road ahead remains challenging, Jaclyn’s unwavering spirit and commitment to raising awareness about pancreatic cancer underscore the critical need for continued research and funding in the fight against this aggressive disease. Her advocacy work with PanCan serves as a poignant reminder of the transformative impact of clinical trials in offering hope and extending the lives of patients battling advanced-stage cancers.
In the face of adversity, Jaclyn’s story stands as a testament to the power of resilience, love, and the unwavering determination to overcome seemingly insurmountable odds. As she continues to fight her battle with pancreatic cancer, Jaclyn’s journey serves as an inspiring beacon of hope for countless others facing their own struggles with the disease. Through her advocacy and courage, she is not only shaping her legacy but also paving the way for future advancements in pancreatic cancer research and treatment strategies.